Logo image of DHIL

DIAMOND HILL INVESTMENT GRP (DHIL) Stock Fundamental Analysis

USA - NASDAQ:DHIL - US25264R2076 - Common Stock

140.3 USD
-2.45 (-1.72%)
Last: 9/19/2025, 8:00:01 PM
140.3 USD
0 (0%)
After Hours: 9/19/2025, 8:00:01 PM
Fundamental Rating

6

DHIL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 236 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making DHIL a very profitable company, without any liquidiy or solvency issues. DHIL has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year DHIL was profitable.
DHIL had a negative operating cash flow in the past year.
Each year in the past 5 years DHIL has been profitable.
Each year in the past 5 years DHIL had a positive operating cash flow.
DHIL Yearly Net Income VS EBIT VS OCF VS FCFDHIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 18.38%, DHIL belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
The Return On Equity of DHIL (27.96%) is better than 94.12% of its industry peers.
The Return On Invested Capital of DHIL (13.91%) is better than 89.92% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DHIL is significantly above the industry average of 7.59%.
Industry RankSector Rank
ROA 18.38%
ROE 27.96%
ROIC 13.91%
ROA(3y)17.33%
ROA(5y)18.52%
ROE(3y)25.87%
ROE(5y)27.78%
ROIC(3y)17.28%
ROIC(5y)17.99%
DHIL Yearly ROA, ROE, ROICDHIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

With a decent Profit Margin value of 31.71%, DHIL is doing good in the industry, outperforming 76.89% of the companies in the same industry.
In the last couple of years the Profit Margin of DHIL has declined.
With a Operating Margin value of 29.27%, DHIL perfoms like the industry average, outperforming 55.04% of the companies in the same industry.
In the last couple of years the Operating Margin of DHIL has declined.
DHIL has a better Gross Margin (97.53%) than 96.64% of its industry peers.
In the last couple of years the Gross Margin of DHIL has remained more or less at the same level.
Industry RankSector Rank
OM 29.27%
PM (TTM) 31.71%
GM 97.53%
OM growth 3Y-11.48%
OM growth 5Y-3.69%
PM growth 3Y-11.14%
PM growth 5Y-6.63%
GM growth 3Y-0.13%
GM growth 5Y0.01%
DHIL Yearly Profit, Operating, Gross MarginsDHIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

DHIL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, DHIL has less shares outstanding
DHIL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DHIL Yearly Shares OutstandingDHIL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
DHIL Yearly Total Debt VS Total AssetsDHIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 4.74 indicates that DHIL is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.74, DHIL belongs to the best of the industry, outperforming 84.03% of the companies in the same industry.
DHIL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.74
ROIC/WACCN/A
WACCN/A
DHIL Yearly LT Debt VS Equity VS FCFDHIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

DHIL has a Current Ratio of 2.58. This indicates that DHIL is financially healthy and has no problem in meeting its short term obligations.
DHIL has a Current ratio of 2.58. This is in the better half of the industry: DHIL outperforms 76.89% of its industry peers.
DHIL has a Quick Ratio of 2.58. This indicates that DHIL is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of DHIL (2.58) is better than 77.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.58
DHIL Yearly Current Assets VS Current LiabilitesDHIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

DHIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.09%, which is quite impressive.
The Earnings Per Share has been decreasing by -0.64% on average over the past years.
Looking at the last year, DHIL shows a small growth in Revenue. The Revenue has grown by 6.29% in the last year.
DHIL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)21.09%
EPS 3Y-12.26%
EPS 5Y-0.64%
EPS Q2Q%95.13%
Revenue 1Y (TTM)6.29%
Revenue growth 3Y-6.05%
Revenue growth 5Y2.04%
Sales Q2Q%-1.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DHIL Yearly Revenue VS EstimatesDHIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.99, the valuation of DHIL can be described as very cheap.
84.03% of the companies in the same industry are more expensive than DHIL, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.38. DHIL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.99
Fwd PE N/A
DHIL Price Earnings VS Forward Price EarningsDHIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DHIL is valued cheaper than 91.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.36
DHIL Per share dataDHIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The decent profitability rating of DHIL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.20%, DHIL is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.21, DHIL has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, DHIL pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.2%

5.2 History

The dividend of DHIL decreases each year by -7.54%.
DHIL has been paying a dividend for over 5 years, so it has already some track record.
DHIL has decreased its dividend recently.
Dividend Growth(5Y)-7.54%
Div Incr Years0
Div Non Decr Years1
DHIL Yearly Dividends per shareDHIL Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

5.3 Sustainability

34.16% of the earnings are spent on dividend by DHIL. This is a low number and sustainable payout ratio.
The Dividend Rate of DHIL has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP34.16%
EPS Next 2YN/A
EPS Next 3YN/A
DHIL Yearly Income VS Free CF VS DividendDHIL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
DHIL Dividend Payout.DHIL Dividend Payout, showing the Payout Ratio.DHIL Dividend Payout.PayoutRetained Earnings

DIAMOND HILL INVESTMENT GRP

NASDAQ:DHIL (9/19/2025, 8:00:01 PM)

After market: 140.3 0 (0%)

140.3

-2.45 (-1.72%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-29 2025-10-29
Inst Owners68.19%
Inst Owner Change1.73%
Ins Owners8.23%
Ins Owner Change6.97%
Market Cap383.02M
Analysts0
Price TargetN/A
Short Float %2.76%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield 4.2%
Yearly Dividend6.02
Dividend Growth(5Y)-7.54%
DP34.16%
Div Incr Years0
Div Non Decr Years1
Ex-Date08-29 2025-08-29 (1.5)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.99
Fwd PE N/A
P/S 2.53
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB 2.23
EV/EBITDA 7.36
EPS(TTM)17.57
EY12.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.12
FCFYN/A
OCF(TTM)-2.21
OCFYN/A
SpS55.41
BVpS62.85
TBVpS62.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.38%
ROE 27.96%
ROCE 18.96%
ROIC 13.91%
ROICexc 17.6%
ROICexgc 17.6%
OM 29.27%
PM (TTM) 31.71%
GM 97.53%
FCFM N/A
ROA(3y)17.33%
ROA(5y)18.52%
ROE(3y)25.87%
ROE(5y)27.78%
ROIC(3y)17.28%
ROIC(5y)17.99%
ROICexc(3y)23.34%
ROICexc(5y)26.25%
ROICexgc(3y)23.34%
ROICexgc(5y)26.25%
ROCE(3y)23.56%
ROCE(5y)24.52%
ROICexcg growth 3Y-17.02%
ROICexcg growth 5Y-3.76%
ROICexc growth 3Y-17.02%
ROICexc growth 5Y-3.76%
OM growth 3Y-11.48%
OM growth 5Y-3.69%
PM growth 3Y-11.14%
PM growth 5Y-6.63%
GM growth 3Y-0.13%
GM growth 5Y0.01%
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 235.66%
Cap/Sales 1.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.58
Altman-Z 4.74
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)40.09%
Cap/Depr(5y)90.74%
Cap/Sales(3y)0.33%
Cap/Sales(5y)0.7%
Profit Quality(3y)71.6%
Profit Quality(5y)79.38%
High Growth Momentum
Growth
EPS 1Y (TTM)21.09%
EPS 3Y-12.26%
EPS 5Y-0.64%
EPS Q2Q%95.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.29%
Revenue growth 3Y-6.05%
Revenue growth 5Y2.04%
Sales Q2Q%-1.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.01%
EBIT growth 3Y-16.83%
EBIT growth 5Y-1.73%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-123.02%
FCF growth 3Y-15.45%
FCF growth 5Y-22.99%
OCF growth 1Y-116.22%
OCF growth 3Y-14.23%
OCF growth 5Y-21.86%